ArticleNanoscale advances2021
Assessing the parameters modulating optical losses of iron oxide nanoparticles under near infrared irradiation.
Article in Nanoscale advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 30 citations in OpenAlex.
- Engineering iron oxide nanoparticles for enhanced radiosensitization.RSC advances · 2026Article
- Light-Activated Iron Oxide Nanoparticles in Cancer Treatment: Synergistic Roles in Photothermal and Photodynamic Therapy.Cancers · 2026Review
- Photothermal Heating and Real-Time In Situ Luminescent Thermometry with Iron Oxide Core-Silica Shell Nano-Objects.Small (Weinheim an der Bergstrasse, Germany) · 2025Article
- Magnetic hyperthermia in oncology: Nanomaterials-driven combinatorial strategies for synergistic therapeutic gains.Materials today. Bio · 2025Review
- Imaging-guided precision hyperthermia with magnetic nanoparticles.Nature reviews bioengineering · 2025Article
- Iron Oxide Nanoparticles: Parameters for Optimized Photoconversion Efficiency in Synergistic Cancer Treatment.Journal of functional biomaterials · 2024Review
- Chitosan/Alginate Nanogels Containing Multicore Magnetic Nanoparticles for Delivery of Doxorubicin.Pharmaceutics · 2023Article
- Article
- Towards the Standardization of Photothermal Measurements of Iron Oxide Nanoparticles in Two Biological Windows.Nanomaterials (Basel, Switzerland) · 2023Article
- Superparamagnetic Iron Oxide Nanoparticles (SPION): From Fundamentals to State-of-the-Art Innovative Applications for Cancer Therapy.Pharmaceutics · 2023Review
- Nanomedical research and development in Spain: improving the treatment of diseases from the nanoscale.Frontiers in bioengineering and biotechnology · 2023Review
- Gold-Coated Superparamagnetic Iron Oxide Nanoparticles Functionalized to EGF and Ce6 Complexes for Breast Cancer Diagnoses and Therapy.Pharmaceutics · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heating mediated by iron oxide nanoparticles subjected to near infrared irradiation has recently gained lots of interest. The high optical loss values reported in combination with the optical technologies already existing in current clinical practices, have made optical heating mediated by iron oxide nanoparticles an attractive choice for treating internal or skin tumors. However, the identification of the relevant parameters and the influence of methodologies for quantifying the optical losses released by iron oxide nanoparticles are not fully clear. Here, we report on a systematic study of different intrinsic (size, shape, crystallinity, and iron oxidation state) and extrinsic (aggregation, concentration, intracellular environment and irradiation conditions) parameters involved in the photothermal conversion of iron oxide nanoparticles under near infrared irradiation. We have probed the temperature increments to determine the specific loss power of iron oxide nanoparticles with different sizes and shapes dispersed in colloidal suspensions or inside live breast cancer cells. Our results underline the relevance of crystal surface defects, aggregation, concentration, magnetite abundance, excitation wavelength and density power on the modulation of the photothermal conversion. Contrary to plasmonic or magnetic losses, no significant influence of nanoparticle size nor shape was observed on the optical losses released by the studied iron oxide nanoparticles. Interestingly, no significant differences of measured temperature increments and specific loss power values were either observed when nanoparticles were inside live cells or in colloidal dispersion. Our findings highlight the advantages of optical heat losses released by iron oxide nanoparticles for therapeutic applications.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.